Allergan Plc (NASDAQOTH:AGN)

CAPS Rating: 4 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Results 1 - 20 of 40 : 1 2 Next »

Recs

0
Member Avatar 1russianguy (89.25) Submitted: 6/17/2015 3:43:54 PM : Outperform Start Price: $265.07 AGN Score: +10.80

Previously ACT

Recs

0
Member Avatar 401ktimer1 (95.20) Submitted: 6/8/2015 3:59:34 PM : Outperform Start Price: $302.24 AGN Score: +0.89

Low forward P/E stock.

Recs

0
Member Avatar optioncoach (94.49) Submitted: 5/27/2015 12:17:53 PM : Outperform Start Price: $305.06 AGN Score: +0.33

They are the owner of Botox. lol I am buying biotech. I keep adding to this sector until it gets killed. Use reasonable stops and I am also hedging the sector with IBB

Recs

0
Member Avatar DrGoldin (99.77) Submitted: 5/8/2015 8:17:35 PM : Outperform Start Price: $305.77 AGN Score: -0.21

Each time I think this company's earnings can't keep growing, they prove me wrong, and I'm salivating at the recent sell-off.

Recs

0
Member Avatar CellBlock9 (91.39) Submitted: 4/26/2015 11:03:34 AM : Outperform Start Price: $296.95 AGN Score: +3.05

mgk, 295.41

Recs

0
Member Avatar bartlettmi (79.83) Submitted: 4/22/2015 2:01:29 PM : Outperform Start Price: $294.84 AGN Score: +3.01

I believe in the bull case... Botox was a steal.

Recs

0
Member Avatar 23dluxe (26.01) Submitted: 4/22/2015 2:23:39 AM : Outperform Start Price: $294.62 AGN Score: +2.77

Obamacare

Recs

0
Member Avatar derbydog85 (32.80) Submitted: 3/17/2015 8:19:30 PM : Outperform Start Price: $308.50 AGN Score: -3.05

Botox use might be used for depression....Growth pharma company has great pipeline...Plenty of upside ahead.

Recs

0
Member Avatar zojo360 (84.41) Submitted: 3/7/2015 2:58:20 PM : Outperform Start Price: $295.29 AGN Score: +2.26

A key element to Actavis’ growth has been the so-called patent cliff, a period when many of the world’s best-selling drugs are losing patent protection. In fact, Actavis has specifically mentioned in the past the new generic introduction of drugs such as Suboxone, Lidoderm and Concerta as growth drivers.

The UBS price target for the stock is $333. The Thomson/First Call consensus price target is lower at $313.11. Shares closed Tuesday at $296.23.

Recs

0
Member Avatar benyboy (< 20) Submitted: 3/5/2015 9:23:55 AM : Outperform Start Price: $297.10 AGN Score: +2.20

John Paulson

Recs

0
Member Avatar pythonmonte (74.01) Submitted: 2/21/2015 8:46:54 PM : Outperform Start Price: $296.43 AGN Score: +2.58

I hears its one of the four horse men of the apolcospe yhe other 3 GILD,REGN,Clgn.

Recs

0
Member Avatar RugbyViking13 (90.37) Submitted: 9/23/2014 2:24:07 PM : Outperform Start Price: $242.77 AGN Score: +18.53

lexapro - you can never leave

Recs

0
Member Avatar tripleking (62.95) Submitted: 6/17/2014 10:21:35 AM : Outperform Start Price: $213.00 AGN Score: +33.85

good stock

Recs

0
Member Avatar Classical (45.83) Submitted: 3/28/2014 4:51:43 PM : Outperform Start Price: $204.27 AGN Score: +35.30

Excellent management, has not missed earnings since 2006 when the company was formally known as Watson. Growing bottom line organically and continues to cherry pick M&A that makes sense. Snaps up branded drugs coming off patent for its favorably large generic portfolio. This will be 100 billion dollar market cap if management continues its track record. Obama-care benefits this company directly because it generic line is so vast.

The founder ( Dr. Choi) started the company out of his garage!

Recs

1
Member Avatar naughtyguy (32.30) Submitted: 3/13/2014 10:43:49 AM : Underperform Start Price: $215.20 AGN Score: -28.08

34 billion market cap! You have got to be kidding!

Recs

0
Member Avatar DugdaleTiki (42.44) Submitted: 3/3/2014 9:27:18 AM : Outperform Start Price: $213.00 AGN Score: +28.12

2014 Sabrient Pick

Recs

0
Member Avatar StewpotDrew (50.65) Submitted: 2/3/2014 12:13:39 AM : Outperform Start Price: $190.00 AGN Score: +40.86

Drugs.

Recs

0
Member Avatar subsurfacemapper (51.24) Submitted: 1/22/2014 11:47:04 PM : Outperform Start Price: $186.18 AGN Score: +47.52

high RS in ibd and high comp

Recs

0
Member Avatar 1picks (88.79) Submitted: 1/13/2014 2:24:18 PM : Outperform Start Price: $182.72 AGN Score: +49.98

Sabrient

Recs

0
Member Avatar manirg (97.98) Submitted: 12/24/2013 12:28:45 PM : Outperform Start Price: $164.50 AGN Score: +68.42

Undervalued growth stock

Results 1 - 20 of 40 : 1 2 Next »

Featured Broker Partners


Advertisement